NO20010982D0 - FremgangsmÕte for Õ administrere insulinotropiske peptider - Google Patents

FremgangsmÕte for Õ administrere insulinotropiske peptider

Info

Publication number
NO20010982D0
NO20010982D0 NO20010982A NO20010982A NO20010982D0 NO 20010982 D0 NO20010982 D0 NO 20010982D0 NO 20010982 A NO20010982 A NO 20010982A NO 20010982 A NO20010982 A NO 20010982A NO 20010982 D0 NO20010982 D0 NO 20010982D0
Authority
NO
Norway
Prior art keywords
administering
insulinotropic peptides
insulinotropic
peptides
administering insulinotropic
Prior art date
Application number
NO20010982A
Other languages
English (en)
Other versions
NO20010982L (no
Inventor
Benjamin Lee Hughes
Ronald Keith Wolff
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26794577&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20010982(D0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of NO20010982D0 publication Critical patent/NO20010982D0/no
Publication of NO20010982L publication Critical patent/NO20010982L/no

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/007Pulmonary tract; Aromatherapy
    • A61K9/0073Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0078Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a nebulizer such as a jet nebulizer, ultrasonic nebulizer, e.g. in the form of aqueous drug solutions or dispersions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22Hormones
    • A61K38/26Glucagons
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/007Pulmonary tract; Aromatherapy
    • A61K9/0073Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/007Pulmonary tract; Aromatherapy
    • A61K9/0073Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
NO20010982A 1998-08-28 2001-02-27 Fremgangsmåte for å administrere insulinotropiske peptider NO20010982L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US9827398P 1998-08-28 1998-08-28
US10001298P 1998-09-11 1998-09-11
PCT/US1999/019348 WO2000012116A1 (en) 1998-08-28 1999-08-24 Method for administering insulinotropic peptides

Publications (2)

Publication Number Publication Date
NO20010982D0 true NO20010982D0 (no) 2001-02-27
NO20010982L NO20010982L (no) 2001-04-27

Family

ID=26794577

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20010982A NO20010982L (no) 1998-08-28 2001-02-27 Fremgangsmåte for å administrere insulinotropiske peptider

Country Status (21)

Country Link
EP (1) EP0997151B1 (no)
JP (1) JP2002523466A (no)
KR (1) KR20010073033A (no)
CN (1) CN1314818A (no)
AR (1) AR022368A1 (no)
AT (1) ATE347902T1 (no)
AU (1) AU764371B2 (no)
BR (1) BR9913284A (no)
CA (1) CA2341454A1 (no)
CO (1) CO5090908A1 (no)
CZ (1) CZ2001690A3 (no)
DE (1) DE69934380D1 (no)
EA (1) EA200100289A1 (no)
HR (1) HRP20010141A2 (no)
HU (1) HUP0103369A3 (no)
IL (1) IL141241A0 (no)
NO (1) NO20010982L (no)
PE (1) PE20001031A1 (no)
PL (1) PL346317A1 (no)
TR (1) TR200100600T2 (no)
WO (1) WO2000012116A1 (no)

Families Citing this family (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9006175B2 (en) 1999-06-29 2015-04-14 Mannkind Corporation Potentiation of glucose elimination
WO2001051071A2 (en) * 2000-01-11 2001-07-19 Novo Nordisk A/S Transepithelial delivery of glp-1 derivatives
US6540983B1 (en) * 2000-01-25 2003-04-01 Aeropharm Technology Incorporated Medical aerosol formulation
AU2001264789A1 (en) * 2000-06-08 2001-12-17 Eli Lilly And Company Protein powder for pulmonary delivery
NZ523693A (en) * 2000-07-10 2004-08-27 Chiron Corp Macrolide formulations for inhalation and methods of treatment of endobronchial infections
EP1542712A2 (en) * 2001-06-01 2005-06-22 Eli Lilly And Company Glp-1 formulations with protracted time action
KR20040054729A (ko) 2001-10-18 2004-06-25 브리스톨-마이어스 스큅 컴퍼니 인간 글루카곤-유사-펩티드-1 모방체, 및 당뇨병 및 이와관련된 증상의 치료에 있어서 이의 용도
US7238671B2 (en) 2001-10-18 2007-07-03 Bristol-Myers Squibb Company Human glucagon-like-peptide-1 mimics and their use in the treatment of diabetes and related conditions
EP2261250B1 (en) 2001-12-21 2015-07-01 Human Genome Sciences, Inc. GCSF-Albumin fusion proteins
EP1894591B1 (en) 2002-03-20 2013-06-26 MannKind Corporation Cartridge for an inhalation apparatus
JP4828940B2 (ja) * 2002-08-01 2011-11-30 マンカインド コーポレイション 細胞輸送組成物およびこれらの使用
US8921311B2 (en) 2003-08-01 2014-12-30 Mannkind Corporation Method for treating hyperglycemia
DE602004026113D1 (de) 2003-12-18 2010-04-29 Novo Nordisk As Glp-1-verbindungen
US7709639B2 (en) 2004-08-20 2010-05-04 Mannkind Corporation Catalysis of diketopiperazine synthesis
EP1791542B1 (en) 2004-08-23 2015-05-20 Mannkind Corporation Diketopiperazine salts for drug delivery
KR100704447B1 (ko) * 2005-05-16 2007-04-09 정용현 3단계로 코팅되는 김치 유산균의 코팅방법 및 그로부터 제조된 코팅된 김치유산균 및 코팅된 김치 유산균이 함유된 조성물
ES2559677T3 (es) 2005-09-14 2016-02-15 Mannkind Corporation Método de formulación de fármacos basado en aumentar la afinidad de los principios activos por superficies de partículas microcristalinas
SI1965823T1 (sl) * 2005-11-04 2016-09-30 Glaxosmithkline Llc Corporation Service Company Postopki za dajanje hipoglikemičnih sredstev
US8293869B2 (en) 2005-12-16 2012-10-23 Nektar Therapeutics Polymer conjugates of GLP-1
KR20080096809A (ko) 2006-02-22 2008-11-03 맨카인드 코포레이션 디케토피페라진 및 활성제를 포함하는 마이크로입자의 약학특성의 개선 방법
JO2945B1 (en) * 2006-09-13 2016-03-15 سميث كلاين بيتشام كوربوريشن Methods of giving prolonged hypoglycemic agents
EP2502618A3 (en) 2007-04-30 2012-10-03 Novo Nordisk A/S Method for drying a protein composition, a dried protein composition and a pharmaceutical composition comprising the dried protein
JP2009019027A (ja) 2007-07-16 2009-01-29 Hanmi Pharmaceutical Co Ltd アミノ末端のアミノ酸が変異したインスリン分泌ペプチド誘導体
AU2008316634B2 (en) * 2007-10-24 2014-02-27 Mannkind Corporation Method of preventing adverse effects by GLP-1
CA3086027C (en) 2008-06-13 2022-05-17 Mannkind Corporation A dry powder inhaler and system for drug delivery
US8485180B2 (en) 2008-06-13 2013-07-16 Mannkind Corporation Dry powder drug delivery system
DK2300083T3 (da) 2008-06-20 2013-07-22 Mannkind Corp Interaktivt apparat og fremgangsmåde til realtids-profilering af inhalationsforsøg
TWI532497B (zh) 2008-08-11 2016-05-11 曼凱公司 超快起作用胰島素之用途
US8314106B2 (en) 2008-12-29 2012-11-20 Mannkind Corporation Substituted diketopiperazine analogs for use as drug delivery agents
CA2749099A1 (en) 2009-01-08 2010-07-15 Mannkind Corporation Method for treating hyperglycemia with glp-1
EP2405963B1 (en) 2009-03-11 2013-11-06 MannKind Corporation Apparatus, system and method for measuring resistance of an inhaler
BRPI1013154B1 (pt) 2009-06-12 2020-04-07 Mannkind Corp Micropartículas de dicetopiperazina com áreas de superfície específicas definidas, pó seco compreendendo as referidas micropartículas, método para formação das referidasmicropartículas e formação de micropartículas de fumaril diacetopiperazina, uso das referidas micropartículas e sistema de inalação
WO2011056889A1 (en) 2009-11-03 2011-05-12 Mannkind Corporation An apparatus and method for simulating inhalation efforts
RU2531455C2 (ru) 2010-06-21 2014-10-20 Маннкайнд Корпорейшн Системы и способы доставки сухих порошковых лекарств
MX353285B (es) 2011-04-01 2018-01-05 Mannkind Corp Paquete de blister para cartuchos farmaceuticos.
WO2012174472A1 (en) 2011-06-17 2012-12-20 Mannkind Corporation High capacity diketopiperazine microparticles
KR20140095483A (ko) 2011-10-24 2014-08-01 맨카인드 코포레이션 통증을 치료하기 위한 방법 및 조성물
RU2650035C2 (ru) 2012-07-12 2018-04-06 Маннкайнд Корпорейшн Системы и способы доставки сухих порошковых лекарств
WO2014066856A1 (en) 2012-10-26 2014-05-01 Mannkind Corporation Inhalable influenza vaccine compositions and methods
CN105102436B (zh) 2013-03-15 2018-06-12 曼金德公司 微晶二酮哌嗪组合物以及方法
KR102321339B1 (ko) 2013-07-18 2021-11-02 맨카인드 코포레이션 열-안정성 건조 분말 약제학적 조성물 및 방법
CA2920488C (en) 2013-08-05 2022-04-26 Mannkind Corporation Insufflation apparatus and methods
WO2015148905A1 (en) 2014-03-28 2015-10-01 Mannkind Corporation Use of ultrarapid acting insulin
US10561806B2 (en) 2014-10-02 2020-02-18 Mannkind Corporation Mouthpiece cover for an inhaler
WO2018155254A1 (ja) 2017-02-21 2018-08-30 Jfeスチール株式会社 高炭素熱延鋼板およびその製造方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5545618A (en) * 1990-01-24 1996-08-13 Buckley; Douglas I. GLP-1 analogs useful for diabetes treatment
DK36492D0 (da) * 1992-03-19 1992-03-19 Novo Nordisk As Praeparat
NZ250844A (en) * 1993-04-07 1996-03-26 Pfizer Treatment of non-insulin dependant diabetes with peptides; composition
US5512549A (en) * 1994-10-18 1996-04-30 Eli Lilly And Company Glucagon-like insulinotropic peptide analogs, compositions, and methods of use
DE122009000079I2 (de) * 1996-08-30 2011-06-16 Novo Nordisk As Novo Alle Glp-1 derivate
UA65549C2 (uk) * 1996-11-05 2004-04-15 Елі Ліллі Енд Компані Спосіб регулювання ожиріння шляхом периферійного введення аналогів та похідних glp-1 (варіанти) та фармацевтична композиція
EP1019031A4 (en) * 1997-07-18 2003-02-05 Infimed Inc BIODEGRADABLE MACROMERS FOR THE REGULATED RELEASE OF BIOLOGICALLY ACTIVE SUBSTANCES

Also Published As

Publication number Publication date
AU5584199A (en) 2000-03-21
JP2002523466A (ja) 2002-07-30
HUP0103369A2 (hu) 2002-02-28
CZ2001690A3 (cs) 2002-04-17
CO5090908A1 (es) 2001-10-30
ATE347902T1 (de) 2007-01-15
AR022368A1 (es) 2002-09-04
CA2341454A1 (en) 2000-03-09
CN1314818A (zh) 2001-09-26
IL141241A0 (en) 2002-03-10
BR9913284A (pt) 2001-05-15
PE20001031A1 (es) 2000-10-12
TR200100600T2 (tr) 2001-07-23
NO20010982L (no) 2001-04-27
DE69934380D1 (de) 2007-01-25
WO2000012116A1 (en) 2000-03-09
PL346317A1 (en) 2002-01-28
EP0997151B1 (en) 2006-12-13
AU764371B2 (en) 2003-08-14
HUP0103369A3 (en) 2002-03-28
EA200100289A1 (ru) 2001-10-22
EP0997151A3 (en) 2000-09-20
KR20010073033A (ko) 2001-07-31
EP0997151A2 (en) 2000-05-03
HRP20010141A2 (en) 2002-02-28

Similar Documents

Publication Publication Date Title
NO20010982D0 (no) FremgangsmÕte for Õ administrere insulinotropiske peptider
NO20003050D0 (no) Metode for Õ administrere monomere insulinanaloger
FI970388A (fi) Menetelmä kuvasekvenssien kontrastin parantamiseksi
NO982097D0 (no) Peptider
NO982098D0 (no) Peptider
NO20004773D0 (no) Forlenget-frigjøringsblandinger
DE69938817D1 (de) Erstellungsverfahren
ID27841A (id) Turunan-turunan biaril terapeutik
DE69919784D1 (de) Spritze
FI19991887A (fi) Menetelmä kalkopyriitin uuttamiseksi
DE69901014T2 (de) Keilantriebsvorrichtung
DE69941066D1 (de) Beatmungsgeräte
NO20005179D0 (no) Medikament behandling
ID27483A (id) Metoda terapi gen
ID20685A (id) Sediaan-sediaan farmasi silansetron yang distabilkan terhadap rasemisasi
DE60037935D1 (de) Kontinuierliches behandlungssystem
DE50004258D1 (de) Transportvorrichtung
FR2791348B1 (fr) POLYPEPTIDE Npt2B
NO20005148L (no) FremgangsmÕte for Õ fremstille 4-substituerte-1H-indol-3- glyoksamider
NO20012133D0 (no) Smertestillende kur
FI981338A0 (fi) Menetelmä multikomponentti-alfa-interferonin valmistamiseksi
NO20012283D0 (no) Koblede peptider
FR2780440B1 (fr) Plate-forme marchepieds
DE69936533D1 (de) Neue behandlungsmethode
DE29807617U1 (de) Spritze

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application